WCLC: Biomarker could guide Dato-DXd use in lung cancer
A biomarker could help identify patients with lung cancer who are most likely to benefit from treatment with AstraZeneca and Daiichi Sankyo's TROP2-directed drug datopotamab deruxtecan (Dat
NICE clears NHS use of MSD's Welireg for genetic disorder
Patients in England and Wales with a rare genetic disorder will soon be able to access treatment with MSD's Welireg via the NHS, nearly a year after their counterparts in Scotland.
WCLC: Summit trumpets data with Keytruda challenger
MSD's PD-1 inhibitor Keytruda has ruled the immunotherapy of non-small cell lung cancer (NSCLC) for many years, but a bispecific antibody from Summit Therapeutics and partner Akeso looks li
WCLC: MSD/Daiichi build case for phase 3 ADC for lung cancer
MSD and Daiichi Sankyo have revealed some of the clinical data that prompted them to start pivotal testing of ifinatamab deruxtecan (I-DXd) in patients with previously treated, extensive-st
First bird flu case with no known animal contact seen in US
The US authorities have reported the first-ever case of an H5 strain of avian influenza without a known occupational exposure to sick or infected animals in the country.
Featured Content
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
PM Society’s sixth Careers Event – 26th February 2025
For the sixth year running the PM Society will be bringing their ‘A Career in Pharmaceutical and Healthcare Communications’ event back to the Royal Society of Medicine.
Complex Bioengineering for Cell Therapies Summit
Unravel Complex TME Biology, Optimize Payload Delivery, & Overcome Early Risks in Developing Advanced Logic Gated & Dual-Targeted Cell Therapies
4th annual Rare & Genetic Kidney Disease Drug Development Su...
Uncover Disease Pathophysiology, Clarify Response Biomarkers, Leverage Electronic Health Records & Implement Patient-Centric Recruitment Strategies to Accelerate Game-Changing Therapies
15th World ADC San Diego 2024
The World’s Largest, Longest-Standing & Most Comprehensive Antibody-Drug Conjugate Conference
LEAP HR: Emerging Biopharma
Lead The Future in Emerging Biopharma: Revolutionize Your HR Strategy, Develop Top Talent & Empower Your Team to Secure Success Amidst Industry Turbul